BioSpace News Archive

Convite®, the best-selling mezcal in Oaxaca, today announced the special release of Una’ – a pink-hued mezcal created to honor Breast Cancer Awareness Month in October.

LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that results from the company’s preclinical research study entitled “Novel AAV-mediated genome editing therapy prevents metabolic decompensation in a mouse model of methylmalonic acidemia” have been published in the peer-reviewed journal PLOS ONE.

Latham Biopharm Group (LBG), in collaboration with researchers from RA Capital Management and Nostrum Biodiscovery, recently published a paper in the Journal of Chemical Information and Modeling (JCIM).

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced scientific presentations at two upcoming conferences.

CARsgen Therapeutics Holdings Limited announces that at the 7th Annual CAR-TCR Summit, in Boston, Massachusetts, the Company gave an oral presentation on the North America Phase 2 clinical trial of zevorcabtagene autoleucel.

AIM ImmunoTech Inc. today announced that it will participate in the Virtual Investor Long COVID Event on Wednesday, September 28, 2022 at 3:00 PM ET.

Medtronic plc (the “Company”) (NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes.